FLT1 and breast cancer: The existence of a distinct autocrine signaling loop is indicated by the production of VEGF-A by breast cancer cells and the activation of VEGF receptors at the surface of these cells, which enables them to promote their own growth, survival and migration by phosphorylation and activation of VEGFR-1/2 or VEGF-induced NRP signaling [50].